KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 98 filers reported holding KALVISTA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $118,353 | +10.9% | 12,290 | +3.7% | 0.00% | 0.0% |
| Q2 2023 | $106,677 | +14.9% | 11,853 | +0.3% | 0.00% | 0.0% |
| Q1 2023 | $92,858 | +18.6% | 11,814 | +2.0% | 0.00% | 0.0% |
| Q4 2022 | $78,274 | -53.7% | 11,579 | -0.4% | 0.00% | 0.0% |
| Q3 2022 | $169,000 | +49.6% | 11,621 | +1.4% | 0.00% | 0.0% |
| Q2 2022 | $113,000 | -31.1% | 11,456 | +3.0% | 0.00% | 0.0% |
| Q1 2022 | $164,000 | +4.5% | 11,119 | -6.6% | 0.00% | 0.0% |
| Q4 2021 | $157,000 | -17.4% | 11,901 | +9.4% | 0.00% | 0.0% |
| Q3 2021 | $190,000 | -28.8% | 10,880 | -2.3% | 0.00% | 0.0% |
| Q2 2021 | $267,000 | -6.3% | 11,139 | +0.3% | 0.00% | 0.0% |
| Q1 2021 | $285,000 | +77.0% | 11,105 | +30.9% | 0.00% | 0.0% |
| Q4 2020 | $161,000 | +56.3% | 8,486 | +4.1% | 0.00% | – |
| Q3 2020 | $103,000 | +2.0% | 8,154 | -2.2% | 0.00% | – |
| Q2 2020 | $101,000 | +77.2% | 8,340 | +11.6% | 0.00% | – |
| Q1 2020 | $57,000 | -59.6% | 7,472 | -5.5% | 0.00% | -100.0% |
| Q4 2019 | $141,000 | +64.0% | 7,903 | +7.2% | 0.00% | – |
| Q3 2019 | $86,000 | -47.6% | 7,371 | -0.7% | 0.00% | -100.0% |
| Q2 2019 | $164,000 | – | 7,421 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,719,576 | $38,088,000 | 25.57% |
| VHCP Management III, LLC | 637,884 | $14,129,000 | 6.60% |
| Vivo Capital, LLC | 1,359,149 | $30,105,000 | 2.82% |
| INTERWEST VENTURE MANAGEMENT CO | 388,766 | $8,611,000 | 2.78% |
| VHCP Management II, LLC | 376,889 | $8,348,000 | 2.63% |
| Samsara BioCapital, LLC | 118,500 | $2,625,000 | 1.73% |
| ACUTA CAPITAL PARTNERS, LLC | 213,000 | $4,718,000 | 1.68% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 187,599 | $4,165,000 | 1.54% |
| Ghost Tree Capital, LLC | 300,000 | $6,645,000 | 1.38% |
| Eventide Asset Management | 1,500,000 | $33,225,000 | 1.01% |